Sarcosinemia: Difference between revisions
Jump to navigation
Jump to search
imported>Thomas E Kelly No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = Sarcosinemia | | Name = Sarcosinemia | | ||
| Line 24: | Line 26: | ||
==References== | ==References== | ||
<br /> | <br /> | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
[[Category: | |||
Latest revision as of 11:00, 15 October 2024
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
| Sarcosinemia | |
|---|---|
| OMIM | 268900 |
Sarcosinemia is characterized by an increased concentration of sarcosine in blood plasma and urine. It can result from an inborn error of sarcosine metabolism or from severe folate deficiency because of the folate requirement for the conversion of sarcosine to glycine. It is thought to be a benign condition causing no symptoms.
For a thorough scientific overview of sarcosineia, one can consult chapter 89 of OMMBID[1]. For more online resources and references, see inborn errors of metabolism.
References
- ↑ Charles Scriver, Beaudet, A.L., Valle, D., Sly, W.S., Vogelstein, B., Childs, B., Kinzler, K.W. (Accessed 2007). The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill. - Summaries of 255 chapters, full text through many universities. There is also the OMMBID blog.